Literature DB >> 12874152

Adverse events with Zyban (buproprion).

Michael Kolber, G Richard Spooner, Olga Szafran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12874152      PMCID： PMC164969     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

Authors:  D E Jorenby; S J Leischow; M A Nides; S I Rennard; J A Johnston; A R Hughes; S S Smith; M L Muramoto; D M Daughton; K Doan; M C Fiore; T B Baker
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

2.  Drug safety without borders: concerns about bupropion.

Authors:  Barbara Mintzes; Ken Bassett; James M Wright
Journal:  CMAJ       Date:  2002-09-03       Impact factor: 8.262

3.  A comparison of sustained-release bupropion and placebo for smoking cessation.

Authors:  R D Hurt; D P Sachs; E D Glover; K P Offord; J A Johnston; L C Dale; M A Khayrallah; D R Schroeder; P N Glover; C R Sullivan; I T Croghan; P M Sullivan
Journal:  N Engl J Med       Date:  1997-10-23       Impact factor: 91.245
  3 in total
  1 in total

Review 1.  Methods for smoking cessation and treatment of nicotine dependence.

Authors:  Aracy Pereira Silveira Balbani; Jair Cortez Montovani
Journal:  Braz J Otorhinolaryngol       Date:  2005 Nov-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.